Insiders Nurix Therapeutics, Inc.

Equities

NRIX

US67080M1036

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
14.95 ^USD	+7.25%		+5.58%	+44.86%

05-14	Stephens Initiates Nurix Therapeutics With Overweight Rating, $20 Price Target	MT
04-12	Sector Update: Health Care Stocks Steady Pre-Bell Friday	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stefani A. Wolff Resigns from Nurix Therapeutics, Inc. as Chief Operating Officer and Executive Vice President of Product Development	10/04/23	CI
Nurix Therapeutics, Inc. Appoints Edward C. Saltzman to its Board of Directors	14/09/22	CI
Nurix Therapeutics, Inc. Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer	03/08/22	CI
Nurix Therapeutics, Inc. announces Resignation of Clay B. Siegall as Class II Member of the Board and as Member of the Board’s Compensation Committee and Development Advisory Committee	16/05/22	CI
Nurix Therapeutics, Inc. Announces Resignation of Jeffrey K. Tong as Class II Member of the Board and as a Member of the Board's Audit Committee and Compensation Committee	07/03/22	CI
Nurix Therapeutics, Inc. Announces Appointments of Judith A. Reinsdorf and Paul M. Silva to Its Board of Directors, Effective October 1, 2021	30/09/21	CI
Insider Sell: Nurix Therapeutics	08/09/21	MT
Nurix Therapeutics, Inc. Announces Appointment of Stefani A. Wolff as Chief Operating Officer and Executive Vice President of Product Development	21/06/21	CI
Nurix Therapeutics, Inc. Announces Resignation of Leon Chen as A Member of the Nominating and Corporate Governance Committee	01/06/21	CI
Nurix Therapeutics, Inc. Appoints Clay Siegall to Board of Directors	01/06/21	CI
Nurix Therapeutics, Inc. Announces Executive Changes , Effective November 1, 2020	26/10/20	CI
Nurix Therapeutics, Inc. Announces Addition of Dr. Jason Kantor to Its Management Team	13/07/20	CI
Nurix Therapeutics, Inc. Announces Management Changes	16/06/20	CI
Nurix Therapeutics, Inc. Announces Executive Changes	14/11/19	CI
Nurix Therapeutics Announces Key Additions to its Board of Directors	08/10/19	CI
Nurix Appoints Dr. Nancy Pryer as Chief Development Officer	08/05/18	CI
Nurix, Inc. Appoints Robert Tjian to the Board of Directors	06/12/16	CI
Nurix, Inc. Announces Executive Changes	03/05/16	CI
Nurix, Inc. Announces Board Changes	03/05/16	CI
Nurix, Inc. Announces Management Changes	18/09/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Nurix Therapeutics, Inc.

Equities

NRIX

US67080M1036

Insiders

Filters